
ASCO 2025: Sacituzumab govitecan helps some patients with PD-L1-positive triple-negative breast cancer live longer without cancer progression
- ASCO 2025: Artificial intelligence assistance can help improve accuracy in identifying HER2-low and HER2-ultralow breast cancers, avoid misclassification
- Global warming may raise women’s cancer risk
- ESMO Breast 2025: Immunotherapy research shows promising results for patients with advanced HER2-positive breast cancer

Episode 1: Nothing to fear? Facing the challenge of fear of cancer recurrence
Join Medical Oncologist and International Cancer Survivorship Expert, Professor Bogda Koczwara AM for Series 2 of Supportive Care Matter. In this episode, Bogda chats to Professor Sophie Lebel and A/Professor Ben Smith about their work to alleviate Fear of Cancer Recurrence.
Recent Events
Industry Spotlight

Building the AI-enabled medical school of the future: A new era in clinician education?
In a viewpoint letter published in JAMA on 31 March 2025, Marc D. Succi, Bernard S. Chang and Arya S.…